MedPath

Internet-Delivered Cognitive Behaviour Therapy for Adolescent Depression

Not Applicable
Completed
Conditions
Depression
Anxiety
Registration Number
NCT02363205
Lead Sponsor
Linkoeping University
Brief Summary

The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (CBT) is a feasible approach in the treatment of depressive symptoms and comorbid anxiety symptoms.

Detailed Description

As above

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Be between the ages of 15-19 years old
  • Have symptoms of depression, major depression
Exclusion Criteria
  • Suicidal ideation
  • Alcohol addiction
  • other major primary psychiatric disorder
  • Ongoing psychological treatment
  • recent (during last 4 weeks) change in psychiatric medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Beck Depression InventoryBaseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Secondary Outcome Measures
NameTimeMethod
Beck Anxiety Inventory (BAI)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Knowledge of CBT strategies (developed by the research group)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Patient Health Questionnaire (PHQ)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment

Social Interaction Anxiety Scale (SIAS)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

The Mood and Feelings Questionnaire (MFQ)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

The General Self-Efficacy Scale (GSE)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Subscale Life activites, WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Trial Locations

Locations (1)

Linköping University

🇸🇪

Linköping, Östergotland, Sweden

Linköping University
🇸🇪Linköping, Östergotland, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.